Through the 90-day period concluding February 19, 2026, Mineralys Therapeutics's top three insider stakeholders include Director Brian Taylor Slingsby (7.90Mn shares), TenPercentOwner Biocapital Gp, Llc Samsara (5.67Mn shares), Director Capital Management, L.P. Ra (5.46Mn shares).
| Holder | Position | Shares | Report Date |
|---|---|---|---|
| Brian Taylor Slingsby | 7,903,838 | 21 Nov, 2025 | |
| Biocapital Gp, Llc Samsara | 5,674,916 | 17 Mar, 2025 | |
| Capital Management, L.P. Ra | 5,456,521 | 08 Sep, 2025 | |
| Healthcare Investments (Cayman) Ltd. Hbm | 3,218,106 | 16 Feb, 2023 | |
| Jon Congleton | Chief Executive Officer | 639,151 | 13 Jan, 2026 |
| Srinivas Akkaraju | 588,235 | 08 Sep, 2025 | |
| David Malcom Rodman | Chief Medical Officer | 44,089 | 17 Feb, 2026 |
| Adam Scott Levy | Cfo And Secretary | 8,638 | 13 Jan, 2026 |
* Please note that the shares above only reflect shares from the fund portfolio and the institutional portfolio. Shares from the personal portfolio are excluded from this Institutional Ownership Page. See these insiders' latest transactions here on Insider Page.
| Transaction Date | Insider Name | Security Class | Transaction Type | Shares Traded | Price | Shares Remaining | Ownership | Code |
|---|---|---|---|---|---|---|---|---|
| 17 Feb, 2026 | David Malcom Rodman | Common Stock | D | 417 | $27.59 | 44,089 | D | S |
| 17 Feb, 2026 | David Malcom Rodman | Common Stock | A | 417 | $15.44 | 44,506 | D | M |
| 13 Feb, 2026 | David Malcom Rodman | Common Stock | D | 3,541 | $27.33 | 50,437 | D | S |
| 13 Feb, 2026 | David Malcom Rodman | Common Stock | A | 4,166 | $14.25 | 54,603 | D | M |
| 13 Feb, 2026 | David Malcom Rodman | Common Stock | D | 6,348 | $27.58 | 44,089 | D | S |
| 13 Feb, 2026 | David Malcom Rodman | Common Stock | A | 3,541 | $10.20 | 53,978 | D | M |
| 13 Feb, 2026 | David Malcom Rodman | Common Stock | D | 4,166 | $27.33 | 50,437 | D | S |
| 12 Feb, 2026 | David Malcom Rodman | Common Stock | D | 5,828 | $28.94 | 50,958 | D | S |
| 12 Feb, 2026 | David Malcom Rodman | Common Stock | A | 6,349 | $1.08 | 56,786 | D | M |
| 12 Feb, 2026 | David Malcom Rodman | Common Stock | D | 521 | $29.64 | 50,437 | D | S |
| 09 Feb, 2026 | David Malcom Rodman | Common Stock | A | 2,171 | $16.00 | 52,608 | D | M |
| 09 Feb, 2026 | David Malcom Rodman | Common Stock | D | 2,171 | $30.21 | 50,437 | D | S |
| 20 Jan, 2026 | David Malcom Rodman | Common Stock | D | 416 | $32.10 | 50,437 | D | S |
| 20 Jan, 2026 | David Malcom Rodman | Common Stock | A | 416 | $15.44 | 50,853 | D | M |
| 14 Jan, 2026 | David Malcom Rodman | Common Stock | D | 11,367 | $32.61 | 50,437 | D | S |
| 13 Jan, 2026 | David Malcom Rodman | Common Stock | A | 3,542 | $10.20 | 65,346 | D | M |
| 13 Jan, 2026 | David Malcom Rodman | Common Stock | D | 7,709 | $32.75 | 61,804 | D | S |
| 13 Jan, 2026 | David Malcom Rodman | Common Stock | A | 4,167 | $14.25 | 69,513 | D | M |
| 12 Jan, 2026 | Jon Congleton | Common Stock | D | 7,117 | $33.15 | 639,151 | D | S |
| 12 Jan, 2026 | Jon Congleton | Common Stock | D | 9,119 | $32.21 | 646,268 | D | S |